A Study Of Patient Reported Outcomes Following Percutaneous Lung Ablation

Overview

About this study

The purpose of this study is to determine the characteristics of recovery following percutaneous ablation of lung tumors based patient reported outcomes.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Undergoing percutaneous lung ablation

 

Exclusion Criteria:

  • Decline to participate in research

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 01/12/2026. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ahmad Parvinian, M.D.

Open for enrollment

Contact information:

Desirae Howe-Clayton

5072550111

howe.desirae@mayo.edu

More information

Publications

Publications are currently not available